menu
    • menu

    Company profile for Evive Biotech

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Evive Biotech is a global biologics company with Asian roots, developing a portfolio of novel biological therapies for patients and healthcare professionals worldwide. We leverage our two proprietary technology platforms, DiKine™ and ITab™, to advance a series of innovative drug candidates for oncology and inflammatory disorders. Founded in 2004, we have over 200 employees today with operations in the US, Singapore and...
    Evive Biotech is a global biologics company with Asian roots, developing a portfolio of novel biological therapies for patients and healthcare professionals worldwide. We leverage our two proprietary technology platforms, DiKine™ and ITab™, to advance a series of innovative drug candidates for oncology and inflammatory disorders. Founded in 2004, we have over 200 employees today with operations in the US, Singapore and China. We adopt a holistic approach to drug development, combining exceptional research and commercialization capabilities with world class in-house regulatory expertise to bring innovative therapies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Evive BiotechUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1200 Highway 22 East, Suite 2000, Bridgewater, New Jersey 08807
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.evivebiotech.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/evive-biotech/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Evive Biotech's Biologic Ryzneuta (efbemalenograstim alpha) Receives Approval in the U.S.
    Evive Biotech's Biologic Ryzneuta (efbemalenograstim alpha) Receives Approval in the U.S.

    16 Nov 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761134

    FDA
    16 Nov 2023
    Share Share
    Aurobindo unit, Evive Biotech ink licensing pact to commercialise Ryzneuta in US
    Aurobindo unit, Evive Biotech ink licensing pact to commercialise Ryzneuta in US

    24 Nov 2022

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-unit-evive-biotech-ink-licensing-pact-to-commercialise-cin-treatment-product-in-us/articleshow/95708321.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    24 Nov 2022
    Share Share
    Evive enters agreement with Acrotech Biopharma to commercialize Ryzneuta in US
    Evive enters agreement with Acrotech Biopharma to commercialize Ryzneuta in US

    24 Nov 2022

    // INDIANPHARMAPOST

    https://www.indianpharmapost.com/news/evive-enters-license-agreement-with-acrotech-biopharma-to-commercialize-ryzneuta-in-us-13335

    INDIANPHARMAPOST
    24 Nov 2022
    Share Share
    Evive Biotech Submits Biologics License Application to US FDA for Ryzneuta™
    Evive Biotech Submits Biologics License Application to US FDA for Ryzneuta™

    31 Mar 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/evive-biotech-submits-biologics-license-application-to-us-fda-for-ryzneutatm-301259250.html

    PRNEWSWIRE
    31 Mar 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search